Serial BLI revealed rapid disease progression in mice treated with untransduced T cells and CBD-IL-12 while those receiving STEAP1-BBζ CAR T cells in combination with CBD-IL-12 therapy demonstrated a significant delay in tumor progression (Fig. 7b, c). The gene discussed is STEAP1; the disease is neoplasm.